Evidence Synthesis
VIVOBIOT has reported a strong quarterly performance, with its Gross Margin accelerated to 75.73%, up from 10.65%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 4 Sept 2026, 15:19
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
VIVOBIOT has reported a strong quarterly performance, with its Gross Margin accelerated to 75.73%, up from 10.65%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 75.73 % | 10.65 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 10.65 % | 11.12 | ▼ |
| REVENUE_GROWTH_YOY | 14.1 % | -89.2 | ▲ |
| PRICE_CHANGE_PERCENT | 2.927 % | — | - |
| DAILY_VOLUME | 13,723 shares | 36,191 | ▼ |
| CLOSE_PRICE | 19.34 INR | 18.79 | ▲ |